LGALS13 Antikörper (AA 1-139)
Kurzübersicht für LGALS13 Antikörper (AA 1-139) (ABIN7868134)
Target
Alle LGALS13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 1-139
-
Verwendungszweck
- Galectin 13 Antibody / LGALS13 / GAL13 (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A recombinant human Galectin-13 protein fragment (amino acids 1-139) was used as the immunogen for the Galectin 13 antibody.
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the Galectin 13 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the Galectin 13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))
-
Andere Bezeichnung
- Galectin 13
-
Hintergrund
- It recognizes a 32 kDa protein, which is identified as homodimer of galectin-13 (also known as PP13). Galectins are a family of soluble beta-galactoside-binding lectins that modulate cell-to-cell adhesion and cell-to-extracellular matrix (ECM) interactions and play a role in tumor progression, pre-mRNA splicing and apoptosis. One such member, galectin-13, is a 139 amino acid protein that contains one galectin domain. Possessing lysophospholipase activity, galectin-13 exists as a disulfide-linked homodimer. Galectin-13 is suggested to have a developmental role in the placenta and may display immunobiological activity in feto-maternal blood-spaces. Screening for galectin-13 in maternal serum during the first trimester of pregnancy may serve as a diagnostic marker to predict preterm pre-eclampsia.
-
UniProt
- Q9UHV8
Target
-